Overview (18 Sep 2026)
Brooks Laboratories Ltd
BROOKS
INE650L01011

Pharmaceuticals
Result was last declared on 13 Aug 2025
0.3

Prev. Close
Previous Close
61.23
Current Close
61.53
Current High
63.89
Current Low
61.02
52 Week High
154.05
52 Week Low
36.9
Resistance 1
63.28
Resistance 2
65.02
Support 1
60.41
Support 2
57.54
Std Deviation
4.65%
DMA 200
67.95
DMA 50
63.85
DMA 20
64.17
Fundamentals and Ratios
Standalone
Trailing EPS
1.97
Forwad EPS
1.05
Trailing P/E
31.23
Forward P/E
58.41
PEG Ratio
-1.86
Mkt. Cap (Cr)
Market Cap (Cr)
181.25
Total Debt(Cr)
Tot. Debt(Cr)
7.28
Reserve (Cr)
93.20
Book Value
41.44
P/BV Ratio
1.48
ROCE(%)
4.00
ROE
4.00
Consolidated
Trailing EPS
8.35
Forwad EPS
2.37
Trailing P/E
7.37
Forward P/E
25.93
PEG Ratio
-0.30
Mkt. Cap (Cr)
Market Cap (Cr)
181.25
Total Debt(Cr)
Tot. Debt(Cr)
7.28
Reserve (Cr)
93.20
Book Value
41.58
P/BV Ratio
1.48
ROCE(%)
4.09
ROE
10.7700

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue22.9620.2116.5723.4525.5185.74
Other Income0.180.440.130.390.221.17
Total Income23.1420.6516.6923.8425.7386.91
Interest0.210.090.160.280.300.84
Expenditure-21.72-20.03-16.39-21.60-23.08-81.10
PBDT0.000.000.000.000.000.00
Depreciation-0.42-0.41-0.39-0.39-0.39-1.59
PBT1.420.610.302.242.655.81
Tax0.000.000.000.000.000.00
Equity29.4629.460.000.0029.4629.46
OPM6.142.951.839.5410.306.68
Net Profit1.420.610.32.242.655.81
NPM6.142.951.839.5410.36.68
EPS0.480.210.10.760.91.97
Consolidated
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue22.9620.2116.5723.4525.5185.7384
Other Income0.180.440.130.390.221.17
Total Income23.1420.6516.6923.8425.7386.91
Interest0.210.090.160.280.300.84
Expenditure-21.72-20.03-16.39-21.60-23.08-81.10
PBDT0.000.000.000.000.000.00
Depreciation-0.42-0.41-0.39-0.39-0.39-1.59
PBT1.420.610.302.242.655.81
Tax0.000.000.000.000.000.00
Equity29.4629.460.000.0029.4629.46
OPM6.142.951.829.3810.306.68
Net Profit-1.791.525.57.989.5824.58
NPM-7.747.3632.9533.4637.2328.29
EPS-0.610.521.872.713.258.35
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings